Stay updated on Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a minor update to the page metadata without changing the displayed study details.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page’s revision/version label in the footer is updated from v3.5.2 to v3.5.3, reflecting a site update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision from v3.4.3 to v3.5.0 was applied.SummaryDifference0.1%

- Check86 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check115 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and the older Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.